As Firm Moves Forward, Ethics Saga Far From Over
685961
By Therese Poletti, Michelle Quinn and Pete Carey, San Jose Mercury News, Calif.  Sep.
180707
Republicans could face ethics investigations for contacting U.S. attorneys about pending cases, a jarring political development only four months after ethical lapses helped cost the GOP control of Congress
164709
The company's stock has had a rough few months, but the business still looks strong.
755741
Expert says most companies still need to improve governance and raise ethics of those at the top. By Jay Loomis. Nell Minow has never been afraid to confront the power brokers in corporate America, first as
28361
A sweeping investigation into the backdating of stock options at more than 100 companies has so far led to relatively few enforcement actions or resolutions.
557571
A long-anticipated merger may soon come true.
299107
Merrill's new CEO isn't shy about shaking things up.
199946
The change in its guidance doesn't rate the drop in its stock price.
721536
The company will likely come out on top regardless of the outcome of the latest controversies.
291543
PeopleSoft's partnership with I.B.M. is an attempt to show that it is moving forward aggressively despite the turmoil created by Oracle's hostile takeover bid.
145837
An advance in stem cell research that was intended to resolve moral differences over the promising but controversial field has ignited fresh conflict instead.
324736
After some key changes, the company may be poised for growth.
650233
The scandal-tagged IPO wants some respect.
667689
The biotech firm advances to next stage of clinical studies in stem cell research.
20822
The company is not flashy, but it may benefit from long-term trends.
247281
Misconduct in the U.S. mutual fund industry is not limited to fund share trading; it's not even limited to funds, say market regulators.
638499
Misconduct in the U.S. mutual fund  industry is not limited to fund share trading; it's not even  limited to funds, say market regulators.